학술논문
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: Phase II results from the north central cancer treatment group (N044B)
Document Type
Article
Author
Source
In: Journal of Thoracic Oncology . (Journal of Thoracic Oncology, May 2008, 3(5):516-520)
Subject
Language
English
ISSN
15561380
15560864
15560864